Clinical Trials Browser

Phase 1/2 × Pathologic Complete Response × Head & Neck × Clear all

NCT07538206 2026-04-20

Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma

Phase 1/2 Not yet recruiting

Pathologic Complete Response, Head and Neck Neoplasms